| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A clinical approach to diagnosis of autoimmune encephalitis
|
Graus, Francesc
|
|
2016
|
15 |
4 |
p. 391-404
14 p.
|
article
|
| 2 |
Adaptation of neurological practice and policy to a changing US health-care landscape
|
Gorelick, Philip B
|
|
2016
|
15 |
4 |
p. 444-450
7 p.
|
article
|
| 3 |
AMG 334 CGRP antibody for migraine: time to celebrate?
|
Ramos, Marta L
|
|
2016
|
15 |
4 |
p. 347-349
3 p.
|
article
|
| 4 |
Autoimmune encephalitis: paving the way for early diagnosis
|
Antoine, Jean-Christophe
|
|
2016
|
15 |
4 |
p. 349-350
2 p.
|
article
|
| 5 |
Brain imaging in the assessment for epilepsy surgery
|
Duncan, John S
|
|
2016
|
15 |
4 |
p. 420-433
14 p.
|
article
|
| 6 |
Corrections
|
|
|
2016
|
15 |
4 |
p. 352-
1 p.
|
article
|
| 7 |
Corrections
|
|
|
2016
|
15 |
4 |
p. 352-
1 p.
|
article
|
| 8 |
Corrections
|
|
|
2016
|
15 |
4 |
p. 352-
1 p.
|
article
|
| 9 |
Cruveilhier versus Charcot
|
Drouin, Emmanuel
|
|
2016
|
15 |
4 |
p. 362-
1 p.
|
article
|
| 10 |
Encephalitis: raising awareness and collaborating in research
|
Easton, Ava
|
|
2016
|
15 |
4 |
p. 353-
1 p.
|
article
|
| 11 |
Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trial
|
Privitera, Michael D
|
|
2016
|
15 |
4 |
p. 365-372
8 p.
|
article
|
| 12 |
Harnessing the integrated stress response for the treatment of multiple sclerosis
|
Way, Sharon W
|
|
2016
|
15 |
4 |
p. 434-443
10 p.
|
article
|
| 13 |
Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions
|
Iranzo, Alex
|
|
2016
|
15 |
4 |
p. 405-419
15 p.
|
article
|
| 14 |
Life after concussion: how plastic is the brain?
|
Morgan, Jules
|
|
2016
|
15 |
4 |
p. 363-
1 p.
|
article
|
| 15 |
Michael Privitera
|
|
|
2016
|
15 |
4 |
p. 362-
1 p.
|
article
|
| 16 |
Myasthenia gravis: subgroup classifications
|
Li, Hai-Feng
|
|
2016
|
15 |
4 |
p. 355-356
2 p.
|
article
|
| 17 |
Myasthenia gravis: subgroup classifications
|
Kohler, Siegfried
|
|
2016
|
15 |
4 |
p. 356-357
2 p.
|
article
|
| 18 |
Myasthenia gravis: subgroup classifications – Authors' reply
|
Gilhus, Nils Erik
|
|
2016
|
15 |
4 |
p. 357-358
2 p.
|
article
|
| 19 |
Neurological expertise is essential for Zika virus infection
|
Shakir, Raad
|
|
2016
|
15 |
4 |
p. 353-354
2 p.
|
article
|
| 20 |
News in brief
|
|
|
2016
|
15 |
4 |
p. 364-
1 p.
|
article
|
| 21 |
Ozanimod: a better or just another S1P receptor modulator?
|
Sørensen, Per Soelberg
|
|
2016
|
15 |
4 |
p. 345-347
3 p.
|
article
|
| 22 |
Philip B Gorelick: changing neurological practice in the USA
|
Kirby, Tony
|
|
2016
|
15 |
4 |
p. 361-
1 p.
|
article
|
| 23 |
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
|
Sun, Hong
|
|
2016
|
15 |
4 |
p. 382-390
9 p.
|
article
|
| 24 |
Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial
|
Cohen, Jeffrey A
|
|
2016
|
15 |
4 |
p. 373-381
9 p.
|
article
|
| 25 |
South Africa: stroke units out of the blue
|
Burton, Adrian
|
|
2016
|
15 |
4 |
p. 359-360
2 p.
|
article
|
| 26 |
The changing US health-care landscape: opportunities and challenges
|
Callaghan, Brian C
|
|
2016
|
15 |
4 |
p. 351-352
2 p.
|
article
|
| 27 |
The safety of generic substitution in epilepsy
|
Perucca, Emilio
|
|
2016
|
15 |
4 |
p. 344-345
2 p.
|
article
|
| 28 |
Top ten research priorities for brain and spine cavernous malformations
|
Salman, Rustam Al-Shahi
|
|
2016
|
15 |
4 |
p. 354-355
2 p.
|
article
|
| 29 |
Zika virus: a little less speculation, a little more action
|
The Lancet Neurology,
|
|
2016
|
15 |
4 |
p. 343-
1 p.
|
article
|
Journal description